
The new drug candidate, developed by Broad Institute and University of Massachusetts Chan Medical School scientists, is a small interfering RNA (siRNA) that binds and snips RNA molecules encoding the prion protein, reducing the amount of the disease-causing protein in the brain. Previous research in animals has shown that lowering prion protein levels can delay onset and slow down the disease.
Fascinating




I’ve been slowly phasing out my YouTube consumption in favor of Nebula, Dropout, and sailing the seven seas